Javascript must be enabled to continue!
James Meredith Puts Ole Miss on Trial
View through CrossRef
Abstract
On June 25, 1962, James Meredith got a major break in his lawsuit against Ole Miss. The U.S. Court of Appeals for the Fifth District in New Orleans found that he had been rejected by the university solely because of race, thereby overturning the lower court’s decision. Four months earlier, Federal District Court Judge Sidney C. Mize, a graduate of the University of Mississippi Law School and a staunch segregationist, had found that Meredith had failed to prove that Ole Miss had a policy of denying admission to Negro applicants. Now the appellate court reversed Mize’s decision. Writing the opinion for the three-judge panel, Judge John Minor Wisdom wrote that “a full review of the record leads inescapably to the conclusion that from the moment the defendants discovered that Meredith was a Negro they engaged in a carefully calculated campaign of delay, harassment, and masterful inactivity . . . a defense designed to discourage and defeat by evasive tactics.” The court ordered the university to admit Meredith and to take all measures to accelerate his admission.
Title: James Meredith Puts Ole Miss on Trial
Description:
Abstract
On June 25, 1962, James Meredith got a major break in his lawsuit against Ole Miss.
The U.
S.
Court of Appeals for the Fifth District in New Orleans found that he had been rejected by the university solely because of race, thereby overturning the lower court’s decision.
Four months earlier, Federal District Court Judge Sidney C.
Mize, a graduate of the University of Mississippi Law School and a staunch segregationist, had found that Meredith had failed to prove that Ole Miss had a policy of denying admission to Negro applicants.
Now the appellate court reversed Mize’s decision.
Writing the opinion for the three-judge panel, Judge John Minor Wisdom wrote that “a full review of the record leads inescapably to the conclusion that from the moment the defendants discovered that Meredith was a Negro they engaged in a carefully calculated campaign of delay, harassment, and masterful inactivity .
.
.
a defense designed to discourage and defeat by evasive tactics.
” The court ordered the university to admit Meredith and to take all measures to accelerate his admission.
Related Results
Epilepsy classification and additional definitions in occipital lobe epilepsy
Epilepsy classification and additional definitions in occipital lobe epilepsy
AbstractAim. To evaluate epileptic children with occipital lobe epilepsy (OLE) in the light of the characteristics of Panayiotopoulos syndrome and late‐onset occipital lobe epileps...
Amaza Lee Meredith
Amaza Lee Meredith
Amaza Lee Meredith (b. 1895–d. 1984) was born in Lynchburg, Virginia, to an African American mother and a white father, a craftsman and builder. Samuel Meredith taught his daughter...
International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19
IMPORTANCE
Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19.
...
The protective role of oleuropein against diethylnitrosamine and phenobarbital induced damage in rats
The protective role of oleuropein against diethylnitrosamine and phenobarbital induced damage in rats
Abstract
Objective
Liver cancer is amongst the most lethal cancers worldwide. Diethylnitrosamine (DEN) and phenobarbital (PB) ar...
Intravenous Vitamin C for Patients Hospitalized With COVID-19
Intravenous Vitamin C for Patients Hospitalized With COVID-19
ImportanceThe efficacy of vitamin C for hospitalized patients with COVID-19 is uncertain.ObjectiveTo determine whether vitamin C improves outcomes for patients with COVID-19.Design...
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
Importance
The longer-term effects of therapies for the treatment of critically ill patients with COVID-19 are unknown.
...
Continuity of care: Perspectives of participants, investigators, and healthcare providers after trial completion in South Africa
Continuity of care: Perspectives of participants, investigators, and healthcare providers after trial completion in South Africa
Abstract
Background
Despite decades of updates to frameworks and guidelines for the conduct of clinical trials, what happens to participants when a trial ends rem...

